Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Obstructive Lung Diseases

  Free Subscription


18.09.2017

1 Allergy
2 Am J Respir Crit Care Med
2 Ann Allergy Asthma Immunol
1 Arch Dis Child
2 Arerugi
5 Chest
6 Eur Respir J
3 J Allergy Clin Immunol
3 J Asthma
2 Lancet
2 N Engl J Med
2 Pediatr Allergy Immunol
1 Pediatr Pulmonol
9 PLoS One
1 Respir Res
3 Thorax


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Allergy

  1. YILMAZ I, Terl M
    Asthma management: A new phenotype-based approach using presence of eosinophilia and allergy.
    Allergy. 2017;72:1587-1589.
    PubMed     Text format    


    Am J Respir Crit Care Med

  2. CARR TF, Zeki AA, Kraft M
    Eosinophilic and Non-Eosinophilic Asthma.
    Am J Respir Crit Care Med. 2017 Sep 14. doi: 10.1164/rccm.201611-2232.
    PubMed     Text format     Abstract available

  3. BHATT SP, Bodduluri S, Hoffman EA, Newell JD Jr, et al
    Computed Tomography Measure of Lung at Risk and Lung Function Decline in Chronic Obstructive Pulmonary Disease.
    Am J Respir Crit Care Med. 2017;196:569-576.
    PubMed     Text format     Abstract available


    Ann Allergy Asthma Immunol

  4. SULLIVAN PW, Ghushchyan V, Navaratnam P, Friedman HS, et al
    The national cost of asthma among school-aged children in the United States.
    Ann Allergy Asthma Immunol. 2017;119:246-252.
    PubMed     Text format     Abstract available

  5. ESTEBAN CA, Everhart RS, Kopel SJ, Klein RB, et al
    Allergic sensitization and objective measures of sleep in urban school-aged children with asthma.
    Ann Allergy Asthma Immunol. 2017;119:238-245.
    PubMed     Text format     Abstract available


    Arch Dis Child

  6. PIKE KC, Levy ML, Moreiras J, Fleming L, et al
    Managing problematic severe asthma: beyond the guidelines.
    Arch Dis Child. 2017 Sep 13. pii: archdischild-2016-311368.
    PubMed     Text format     Abstract available


    Arerugi

  7. ADACHI Y
    OBESITY AND ASTHMA IN CHILDHOOD.
    Arerugi. 2017;66:977-983.
    PubMed     Text format    

  8. KOYA T, Hasegawa T
    RELATION BETWEEN ADULT ASTHMA AND UNDERWEIGHT-NECESSITY TO REVEAL ITS MECHANISM.
    Arerugi. 2017;66:971-976.
    PubMed     Text format    


    Chest

  9. POLVERINO E, Rosales-Mayor E, Dale GE, Dembowsky K, et al
    The Role of Neutrophil Elastase Inhibitors in Lung Diseases.
    Chest. 2017;152:249-262.
    PubMed     Text format     Abstract available

  10. YANAGISAWA S, Papaioannou AI, Papaporfyriou A, Baker JR, et al
    Decreased Serum Sirtuin-1 in COPD.
    Chest. 2017;152:343-352.
    PubMed     Text format     Abstract available

  11. WINSTONE TA, Levy RD, Shojania K, Murphy D, et al
    Organizing Pneumonia in an Adult With Chronic Recurrent Noninfectious Osteomyelitis: A Case Report and Literature Review.
    Chest. 2017;152:e21-e24.
    PubMed     Text format     Abstract available

  12. CHEN LW, McShane PJ, Karkowsky W, Gray SE, et al
    De Novo Development of Bronchiectasis in Patients With Hematologic Malignancy.
    Chest. 2017;152:683-685.
    PubMed     Text format    

  13. DEBRAY MP, Marceau A, Dombret MC, Bunel V, et al
    Bronchiectasis Complicating Lung Volume Reduction Coil Treatment.
    Chest. 2017;152:e57-e60.
    PubMed     Text format     Abstract available


    Eur Respir J

  14. POLVERINO E, Goeminne PC, McDonnell MJ, Aliberti S, et al
    European Respiratory Society guidelines for the management of adult bronchiectasis.
    Eur Respir J. 2017;50.
    PubMed     Text format     Abstract available

  15. O'BYRNE PM, Jenkins C, Bateman ED
    The paradoxes of asthma management: time for a new approach?
    Eur Respir J. 2017;50.
    PubMed     Text format     Abstract available

  16. TO T, Zhu J, Carlsten C, Larsen K, et al
    Do community demographics, environmental characteristics and access to care affect risks of developing ACOS and mortality in people with asthma?
    Eur Respir J. 2017;50.
    PubMed     Text format    

  17. FRICKER M, Gibson PG
    Macrophage dysfunction in the pathogenesis and treatment of asthma.
    Eur Respir J. 2017;50.
    PubMed     Text format     Abstract available

  18. ROBINSON DS, Kariyawasam HH, Heaney LG
    Phase three studies of biologics for severe asthma: could do better?
    Eur Respir J. 2017;50.
    PubMed     Text format    

  19. BUSH A, Pavord ID
    After the asthmas: Star Wars and Star Trek.
    Eur Respir J. 2017;50.
    PubMed     Text format    


    J Allergy Clin Immunol

  20. WYPYCH TP, Marzi R, Wu GF, Lanzavecchia A, et al
    Role of B cells in T helper cell responses in a mouse model of asthma.
    J Allergy Clin Immunol. 2017 Sep 7. pii: S0091-6749(17)31430.
    PubMed     Text format     Abstract available

  21. CHEN J, Miller M, Unno H, Rosenthal P, et al
    Ormdl3 Upregulates Airway Smooth Muscle Proliferation, Contraction, and Ca2+ Oscillations in Asthma.
    J Allergy Clin Immunol. 2017 Sep 7. pii: S0091-6749(17)31427.
    PubMed     Text format     Abstract available

  22. VROMAN H, Bergen IM, van Hulst JAC, van Nimwegen M, et al
    TNFAIP3 levels in lung dendritic cells instruct Th2 or Th17 cell differentiation in eosinophilic or neutrophilic asthma.
    J Allergy Clin Immunol. 2017 Sep 6. pii: S0091-6749(17)31422.
    PubMed     Text format     Abstract available


    J Asthma

  23. TRENT SA, Hasegawa K, Ramratnam SK, Bittner JC, et al
    Variation in Asthma Care at Hospital Discharge by Race/Ethnicity Groups.
    J Asthma. 2017 Sep 11:0. doi: 10.1080/02770903.2017.1378356.
    PubMed     Text format     Abstract available

  24. LIU TL, Taylor YJ, Mahabaleshwarkar R, Blanchette CM, et al
    Shared Decision Making and Time to Exacerbation in Children with Asthma.
    J Asthma. 2017 Sep 11:0. doi: 10.1080/02770903.2017.1378357.
    PubMed     Text format     Abstract available

  25. JOHNSTON CF, Broom M, Shadbolt B, Todd DA, et al
    Smoking in the family is most predictive of the development of childhood asthma in preterm babies <30 weeks gestation: Results of the Respiratory Outcomes Study 2 (REPOS2).
    J Asthma. 2017 Sep 13:0. doi: 10.1080/02770903.2017.1366508.
    PubMed     Text format     Abstract available


    Lancet

  26. WOODCOCK A, Vestbo J, Bakerly ND, New J, et al
    Effectiveness of fluticasone furoate plus vilanterol on asthma control in clinical practice: an open-label, parallel group, randomised controlled trial.
    Lancet. 2017 Sep 8. pii: S0140-6736(17)32397.
    PubMed     Text format     Abstract available

  27. GIBSON P
    Effectiveness trials in asthma: time to SaLSA?
    Lancet. 2017 Sep 8. pii: S0140-6736(17)32398.
    PubMed     Text format    


    N Engl J Med

  28. KO FWS, Wong GWK
    Drug Treatment for Early-Stage COPD.
    N Engl J Med. 2017;377:988-989.
    PubMed     Text format    

  29. WEDZICHA JA
    Airway Mucins in Chronic Obstructive Pulmonary Disease.
    N Engl J Med. 2017;377:986-987.
    PubMed     Text format    


    Pediatr Allergy Immunol

  30. OGAWA K, Tanaka S, Yang L, Arata N, et al
    Beta-2 receptor agonist exposure in the uterus associated with subsequent risk of childhood asthma.
    Pediatr Allergy Immunol. 2017 Sep 11. doi: 10.1111/pai.12805.
    PubMed     Text format     Abstract available

  31. MARTINS C, Silva D, Severo M, Rufo J, et al
    Spirometry adjusted exhaled nitric oxide increases accuracy for assessment of asthma control in children.
    Pediatr Allergy Immunol. 2017 Sep 11. doi: 10.1111/pai.12803.
    PubMed     Text format     Abstract available


    Pediatr Pulmonol

  32. KUZIK BA
    Maybe this is just asthma.
    Pediatr Pulmonol. 2017 Sep 14. doi: 10.1002/ppul.23826.
    PubMed     Text format    


    PLoS One

  33. FARQUHAR M, Penfold C, Benson J, Lovick R, et al
    Six key topics informal carers of patients with breathlessness in advanced disease want to learn about and why: MRC phase I study to inform an educational intervention.
    PLoS One. 2017;12:e0177081.
    PubMed     Text format     Abstract available

  34. JURCA M, Ramette A, Dogaru CM, Goutaki M, et al
    Prevalence of cough throughout childhood: A cohort study.
    PLoS One. 2017;12:e0177485.
    PubMed     Text format     Abstract available

  35. SARLABOUS L, Torres A, Fiz JA, Martinez-Llorens JM, et al
    Inspiratory muscle activation increases with COPD severity as confirmed by non-invasive mechanomyographic analysis.
    PLoS One. 2017;12:e0177730.
    PubMed     Text format     Abstract available

  36. COPOT D, De Keyser R, Derom E, Ionescu C, et al
    Structural changes in the COPD lung and related heterogeneity.
    PLoS One. 2017;12:e0177969.
    PubMed     Text format     Abstract available

  37. MUNOZ-ESQUERRE M, Aliagas E, Lopez-Sanchez M, Escobar I, et al
    Vascular disease in COPD: Systemic and pulmonary expression of PARC (Pulmonary and Activation-Regulated Chemokine).
    PLoS One. 2017;12:e0177218.
    PubMed     Text format     Abstract available

  38. LI L, Hua L, He Y, Bao Y, et al
    Differential effects of formaldehyde exposure on airway inflammation and bronchial hyperresponsiveness in BALB/c and C57BL/6 mice.
    PLoS One. 2017;12:e0179231.
    PubMed     Text format     Abstract available

  39. SONNAPPA S, Martin R, Israel E, Postma D, et al
    Risk of pneumonia in obstructive lung disease: A real-life study comparing extra-fine and fine-particle inhaled corticosteroids.
    PLoS One. 2017;12:e0178112.
    PubMed     Text format     Abstract available

  40. KHEDOE PPSJ, de Kleijn S, van Oeveren-Rietdijk AM, Plomp JJ, et al
    Acute and chronic effects of treatment with mesenchymal stromal cells on LPS-induced pulmonary inflammation, emphysema and atherosclerosis development.
    PLoS One. 2017;12:e0183741.
    PubMed     Text format     Abstract available

  41. NAKAO M, Yamauchi K, Ishihara Y, Omori H, et al
    Prevalence and risk factors of airflow limitation in a Mongolian population in Ulaanbaatar: Cross-sectional studies.
    PLoS One. 2017;12:e0175557.
    PubMed     Text format     Abstract available


    Respir Res

  42. TORAIH EA, Hussein MH, Al Ageeli E, Riad E, et al
    Structure and functional impact of seed region variant in MIR-499 gene family in bronchial asthma.
    Respir Res. 2017;18:169.
    PubMed     Text format     Abstract available


    Thorax

  43. ARBILLAGA-ETXARRI A, Gimeno-Santos E, Barberan-Garcia A, Benet M, et al
    Socio-environmental correlates of physical activity in patients with chronic obstructive pulmonary disease (COPD).
    Thorax. 2017;72:796-802.
    PubMed     Text format     Abstract available

  44. MAKRIS D, Leroy S, Pradelli J, Benzaquen J, et al
    Changes in dynamic lung mechanics after lung volume reduction coil treatment of severe emphysema.
    Thorax. 2017 Sep 11. pii: thoraxjnl-2017-210118.
    PubMed     Text format     Abstract available

  45. LIU S, Zhou Y, Liu S, Chen X, et al
    Association between exposure to ambient particulate matter and chronic obstructive pulmonary disease: results from a cross-sectional study in China.
    Thorax. 2017;72:788-795.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Obstructive Lung Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: